#South Korea #Seoul #blood pressure #Sky Labs #CART Monitor

Introducing the CART Blood Pressure Monitor

Sky Labs, under the leadership of CEO Jack ByungHwan Lee, made waves at the ESC Congress 2026 in Munich, Germany, during a presentation on its innovative blood pressure monitoring device known as CART. This ring-type monitor is being lauded for its utility in the management of patients suffering from atrial fibrillation (AF) and heart failure (HF).

The presentation marked a significant milestone as it highlighted the clinical research outcomes of the CART monitor, which attracted tremendous attention from the medical community, outperforming several major global tech companies. The event included five dedicated sessions focused on presenting new clinical data specific to AF and HF patients.

Study Highlights

Professor Ki-Hong Lee from Chonnam National University Hospital took the stage to present findings from a 24-hour blood pressure monitoring study on patients with AF. He reported an impressive analyzable data rate of approximately 80% using the CART device, demonstrating its potential for effective and ongoing monitoring of nocturnal blood pressure patterns. This continuous tracking is crucial, as fluctuations in blood pressure can be significant during the night when patients are at rest.

Additionally, Professor In-Cheol Kim from Keimyung University Dongsan Hospital shared insights relating to severe heart failure patients, indicating the efficacy of the CART monitor in producing reliable measurements. His research involved a simultaneous evaluation of CART against conventional 24-hour ambulatory blood pressure monitoring (ABPM) systems, revealing a high degree of agreement that sat well within the acceptable error margin set by the European Society of Hypertension (ESH).

A New Standard in Blood Pressure Monitoring

One of the notable advantages of the CART monitor is its capability to provide continuous blood pressure (BP) tracking for patients who previously struggled with traditional measurement methods due to irregular pulses or other complications present in AF and HF cases. The results from various presentations showcased the monitor’s high reliability, aligning with ESH recommendations for cuffless devices, which include several rigorous testing standards such as the Static Test, Device Position Test, and activity-related assessments.

Professor Hae-Young Lee of Seoul National University Hospital further corroborated the CART monitor's reliability by passing all necessary validations. This was further echoed by Professor Eun-Mi Lee from Dongguk University, who illustrated how measuring real BP using the CART device allowed for a successful reduction in medication for a patient suffering from stress and pain linked to conventional cuff usage.

Breathing Disorders and BP Tracking

Impressively, data was also shared on sleep apnea patients by Professor Jong-Chan Youn from Seoul St. Mary's Hospital, who analyzed over 12,000 instances of breathing disturbances among 62 patients. His findings highlighted the CART monitor's responsiveness to sharp surges in blood pressure that occur just after breathing resumes, demonstrating its potential in managing patients with breathing irregularities.

Commitment to Rigorous Standards

Contributions from Professors Seok-Min Kang and George Stergiou conveyed a unified message about Sky Labs' commitment to robust verification of their devices. They emphasized that Sky Labs is one of the few companies worldwide adhering to the stringent ESH validation criteria exclusive for cuffless devices.

Expanding Market Presence

The CART monitor stands out in the medical field, utilizing PPG sensors and advanced AI deep learning technology for uninterrupted BP measurement through a comprehensive finger ring. With prescriptions exceeding 300,000 across more than 2,000 healthcare institutions in Korea, the device has already made significant strides towards becoming a standard in cardiovascular management. Moreover, it has been officially incorporated into the 2026 Korean Society of Hypertension Guidelines, marking a world-first for ring-type cuffless monitors.

CEO Jack ByungHwan Lee stated, “At the ESC 2026, we demonstrated CART's game-changing potential for managing complex cardiovascular conditions such as AF and HF. With our extensive experience in the Korean market, we are poised to accelerate our efforts to penetrate European and global markets.”

Conclusion

As healthcare futurists look to leverage technology for better patient outcomes, the CART blood pressure monitor by Sky Labs offers a pioneering solution. This innovative device combines advanced technology with clinical efficacy, promising to enhance the standard of care for patients battling atrial fibrillation and heart failure. It signifies a crucial step forward in remote health monitoring, providing both physicians and patients with greater control over ongoing health management.